#ACTRIMS2019 – Upcoming Forum Will Include Interactive, Case-based Discussion About MS Therapeutic Landscape

#ACTRIMS2019 – Upcoming Forum Will Include Interactive, Case-based Discussion About MS Therapeutic Landscape

The Physicians’ Education Resource will host an interactive, case-based discussion on the latest therapeutics in multiple sclerosis (MS).

The free educational program, part of the 2019 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum (Feb. 28 -March 2), aims to inform clinicians about how to best manage MS treatment options given the ever-changing therapeutic landscape.

The satellite symposium, “Interpreting the Therapeutic Landscape in Multiple Sclerosis,” will take place from 6:30 to 7:45 a.m. (CST) March 2, at the Hilton Anatole Governors Lecture Hall in Dallas, Texas.

Treatment options for MS are constantly changing. In the past few years, multiple new treatments have emerged, including novel oral therapies and disease-modifying treatments.

Given these options, clinicians can personalize treatment programs for MS patients now more than ever. That’s because each patient differs in disease severity, treatment effectiveness and tolerability, and considerations for lifestyle, adherence, preferences, and concerns.

To implement new therapies for successful personalized treatment of MS, clinicians need to stay informed about the latest research regarding new therapies that may enhance their patients’ outcomes. For example, failure to initiate an early and effective treatment plan with proven novel therapies can result in missed opportunities to preserve or improve a patient’s long-term health, abilities, and quality of life.

Also, new clinical information is often released about common side effects caused by certain therapies that were not known when the therapeutic was approved. Clinicians must stay informed to best manage these common side effects in the treatment of MS patients.

The symposium will involve in-depth panel discussions of challenging clinical cases and knowledge gaps with an interactive audience response system. Together, experts and the audience will debate how to interpret and apply new MS clinical trial data on the therapeutic landscape.

There also will be discussion about MS clinical practice patterns (i.e., “How would a clinician treat a patient considering the information available?”), and clinical practice preference among MS participants.

All attendees of the ACTRIMS forum can participate in the symposium, including neurologists and MS sub-specialists, namely nurse practitioners, physician assistants, and other healthcare professionals.

“The landscape for multiple sclerosis continues to change, with different options for individual treatment based on different factors for the patient and the disease,” Phil Talamo, president of Physicians’ Education Resource, said in a press release.

“We are excited to inform clinicians about the latest research on novel therapies that could enhance the therapeutic landscape and improve patient outcomes, through our exciting case-based format,” Talamo added.

This live activity is accredited by the Accreditation Council for Continuing Medical Education for 1.0 AMA PRA Category 1 Credits for physicians.

Attendance is on a first-come, first-served basis. Registration can be done online, or by phone at (888) 949-0045 or (609) 378-3701.

2 comments

  1. Julie A Morrison says:

    So for patients their costs will increase and Insurance Cos and Medicare will lessen. When are the Pharmaceutical Cos. reduce their cost so the treatment is not astronomically skewed in their favor.

  2. Mody says:

    I do not believe in the FDA drugs anymore… I have my own way to treat myself cause the FDA became approves a fake drugs like Ambyra … etc.

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This